0001567619-21-021161.txt : 20211124 0001567619-21-021161.hdr.sgml : 20211124 20211124160629 ACCESSION NUMBER: 0001567619-21-021161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211122 FILED AS OF DATE: 20211124 DATE AS OF CHANGE: 20211124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobs Jeffrey W CENTRAL INDEX KEY: 0001611193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 211446467 MAIL ADDRESS: STREET 1: C/O ARDELYX, INC. STREET 2: 34175 ARDENWOOD BLVD, SUITE 100 CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 4 1 doc1.xml FORM 4 X0306 4 2021-11-22 0 0001437402 ARDELYX, INC. ARDX 0001611193 Jacobs Jeffrey W C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 200 FREMONT CA 94555 0 1 0 0 Chief Scientific Officer Common Stock 2021-11-22 4 S 0 5000 0.9763 D 120237 D Common Stock 2021-11-22 4 S 0 754 0.9919 D 119483 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. /s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs 2021-11-24